MARTIN MIDSTREAM PARTNERS L.P.

MMLP
About the company

Martin Midstream Partners L.P., together with its subsidiaries, provides terminalling, processing, and storage services for petroleum products and by-products in the United States. It operates through four segments: Terminalling and Storage, Transportation, Sulfur Services, and Specialty Products.

Country: United StatesPrice: $2.24Market Cap: $87.6M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

1 / 13

NEUTRAL / FAIL

Median fair value

$4.52

+101.8% vs price

Models with upside

4 / 17

Positive margin of safety

Strongest signal

Models split on MMLP at $2.24 — fair values range $0.69–$11.66

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #839 (Top 27.1%)FAILFAILPASSFAILFAILFAILFAILFAILPASSNEUTRALFAILFAILFAIL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A+30.7%N/A+80.8%N/AN/A+61.6%-224.6%N/AN/A+50.4%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

TTM ended 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-26

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-10-26

Score computed: 2026-11-14

Where It Passes

  • Valuation models80% pass✓ 4✗ 1▾

    Models split on MMLP at $2.24 — fair values range $0.69–$11.66

    Buffett fair value$3.23
    ✓Buffett+30.7% margin vs $2.24
    Greenblatt fair value$11.66
    ✓Greenblatt+80.8% margin vs $2.24
    Munger fair value$5.83
    ✓Munger+61.6% margin vs $2.24
    Pabrai fair value$0.69
    ✗Pabrai-224.6% margin vs $2.24
    Ackman fair value$4.52
    ✓Ackman+50.4% margin vs $2.24

Where It Falls Short

  • Profitability0% pass✓ 4✗ 31▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)8/25 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)16/25 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)8.5%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)6.8% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$10.7M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROEN/A (negative equity)
    ✗Lynch> 15%
    EBIT / Enterprise Value8.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=8.9%, ROC=15.0%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-2.82%
    ✗PiotroskiROA > 0
    ROA Change YoY-0.97% -> -2.82% (delta: -1.86%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=8.83%, ROA=-2.82%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY58.0% -> 55.5%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-1.1%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity
    ✗Dreman> 12%
    Margin of Safety
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity11.7% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency16/25 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue6.2%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend8.4% (2023) -> 6.8% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 51.2% -> 55.5%, operating margin 8.4% -> 6.8%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-12.72%; #4297/6340 (top 67.8%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+76.09%; #281/3702 (top 7.6%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0094; #779/5884 (top 13.2%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR21.4% over 3 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years3/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Debt & Leverage0% pass✗ 15▾

    All 12 investors flag MMLP's debt & leverage

    LT Debt vs Net Current AssetsLT Debt $476.6M vs NCA $48.5M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: N/A (negative equity), IC: 0.9x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / EquityN/A (negative equity)
    ✗Lynch< 0.33
    Cash - Long-term Debt$-476.5M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change81.27% -> 81.93%
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.35
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt LevelsN/A (non-positive equity)
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=0.9x, D/EBITDA=4.7x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Growth13% pass✓ 1✗ 12▾

    7 of 8 flag MMLP's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 39.3% vs Rev: 13.2%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency16/25 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-11.3%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency2/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 51.2% -> 55.5%, operating margin 8.4% -> 6.8%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR1.3%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR21.4% over 3 years
    ✗Neff7%-20% annualized
  • Efficiency13% pass✓ 3✗ 8▾

    7 of 8 flag MMLP's efficiency — Graham, Greenblatt, Piotroski +4 more

    Current Ratio1.35
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)11.5%
    ✓Buffett> 10%
    ROIC - WACC+1.5%
    ✓BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)15.0%
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.13 -> 1.05
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.31x -> 1.37x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities1.35
    ✗Dreman> 1.5
    Return on Invested Capital10.4%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=14.8%; FY2024: ROIC=12.3%; FY2025: ROIC=11.3%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)2/5 years above 12% (latest 11.3%)
    ✗SleepROIC > 12% in a majority of years
  • Verdicts13% pass✓ 2✗ 14▾

    Split decision: 13 FAIL · 2 PASS · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (2/9)✗LynchFAIL (0/7)✗GreenblattRank #839✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (1/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (2/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (1/7)✗OshaughnessyFAIL (Rank #814/963 (Top 84.5%))
  • Valuation23% pass✓ 6✗ 22▾

    10 of 13 flag MMLP's valuation — Graham, Lynch, Greenblatt +7 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value8.9%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=8.9%, ROC=15.0%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)1.9x
    ✓Dreman< 8x
    Price / Book Value per ShareN/A (negative BVPS)
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=12.2%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=24.4%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share4.1x
    ✓Ackman<= 25
    Price vs. Trailing Low113% of trailing low ($1.98)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-12.72%; #4297/6340 (top 67.8%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization-1.0784; #6046/6449 (top 93.8%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+9.2102; #335/5247 (top 6.4%)
    ✓OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-21.29%; #3537/4519 (top 78.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-12.16%; #3554/6202 (top 57.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow50% pass✓ 7✗ 5▾

    5 of 10 pass — Buffett, Lynch, Ackman +2 more object

    Free Cash Flow Proxy$10.7M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-18.7M
    ✗LynchPositive and growing
    Operating Cash Flow$46.1M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=8.83%, ROA=-2.82%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)1.9x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=24.4%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive15/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-21.3%
    ✗Ackman>= 4%
    Price / FCF per Share4.1x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency25/25 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-18.7M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-21.29%; #3537/4519 (top 78.3%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Wholesale
SIC Sector: Nondurable Goods Wholesale
Size: Micro Cap($87.6M)
Revenue: $716.1M+1.2% YoY
Net Income: $14.7M-183.2% YoY

Financial Snapshot

Operating Margin6.8%
Return on Equity17.2%
Debt / Equity-4.99
Current Ratio1.05
EPS (Diluted)$-0.37
Shares Retired−0.1% / −0.4% 2y

Similar Companies

MCKMCKESSON CORP
$127.3B
GWWW.W. GRAINGER, INC.
$69.7B
CAHCARDINAL HEALTH INC
$65.0B
SYYSYSCO CORP
$38.0B

Shareholder Return

Fiscal 2025

Issued 0.1% of shares last year, 0.4% issued over two.

Buybacks
—
Dividends
$797.0K

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-23
FY 2024
Sources
  • 10-K · 2025-02-24
FY 2023
Sources
  • 10-K · 2024-02-21
FY 2022
Sources
  • 10-K · 2023-03-02
FY 2021
Sources
  • 10-K · 2022-03-01
Market Cap$87.6Mcurrent------$109.2Mest.$140.4Mest.$87.0Mest.$123.0Mest.$115.4Mest.
Revenue$807.2M↑13%$231.7M↑37%$213.6M↑18%$187.7M↓3%$716.1M↑1%$707.6M↓11%$798.0M↓22%$1.0B↑15%$882.4M
Operating Income$50.2M↑17%$10.2M↑48%$19.3M↑29%$8.0M↓44%$48.9M↓15%$57.3M↓14%$66.7M↑30%$51.3M↓11%$57.3M
Net Income-$11.2M↑46%-$4.1M↑51%$2.6M↑210%-$6.8M↓554%-$14.7M↓183%-$5.2M↓14%-$4.5M↑56%-$10.3M↓4798%-$211.0K
EPS (Diluted)--$-0.10↑52%$0.07↑217%$-0.17↓467%$-0.37↓185%$-0.13↓18%$-0.11↑58%$-0.26↓2500%$-0.01
Gross Margin————55.5%↓4%58.0%↑13%51.2%↑32%38.8%↓2%39.6%
Operating Margin6.2%↑3%4.4%↑8%9.0%↑9%4.3%↓43%6.8%↓16%8.1%↓3%8.4%↑66%5.0%↓22%6.5%
ROE11.8%↓53%———17.2%↑132%7.4%↑5%7.0%↓60%17.4%↑3858%0.4%
Total Debt$476.6M↑8%$476.6M↑8%$453.7M↑6%$458.4M↑2%$428.0M↓2%$437.6M↑4%$421.2M↓18%$512.9M↑3%$499.2M
Shareholders' Equity-$94.5M↓14%-$94.5M↓14%-$90.2M↓22%-$92.7M↓29%-$85.8M↓22%-$70.4M↓9%-$64.6M↓9%-$59.4M↓24%-$48.0M
Current Ratio1.35↑13%1.35↑13%1.21↑7%1.26↓7%1.05↓7%1.13↓1%1.14↓40%1.90↑14%1.67
Debt / Equity-5.04↑5%-5.04↑5%-5.03↑13%-4.95↑22%-4.99↑20%-6.21↑5%-6.52↑24%-8.63↑17%-10.39
Operating Cash Flow$16.0M↓76%-$4.9M↓302%$12.2M↓61%-$13.8M↓129%$46.1M↓5%$48.4M↓65%$137.5M↑751%$16.1M↓55%$35.7M
Free Cash Flow-$18.7M↓147%-$15.7M↓98%$2.7M↓90%-$21.3M↓79%$21.4M↑237%$6.3M↓94%$103.2M↑1030%-$11.1M↓156%$19.7M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Wholesale

MMLP vs Peers — Financial Grading

Revenue$716.1MBottom 25%
Net Income$14.7MBottom 25%
ROE17.2%Median
D/E-4.99Top 25%
Op. Margin6.8%Median
Curr. Ratio1.05Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
MCKESSON CORPMCK$127.3B$1102.81$403.4B$4.8B-219.2%-3.001.5%0.852/95/94/70/3F-Score 61/11
W.W. GRAINGER, INC.GWW$69.7B$1489.30$17.9B$1.7B45.7%0.6713.9%2.834/96/94/71/3F-Score 65/11
CARDINAL HEALTH INCCAH$65.0B$281.10$254.2B$1.7B-59.5%-3.081.0%0.882/93/93/70/3F-Score 81/11
SYSCO CORPSYY$38.0B$77.10$81.4B$1.8B99.9%—3.8%1.213/95/95/71/3F-Score 42/11
RELIANCE, INC.RS$21.8B$427.33$14.3B$739.4M10.3%0.207.1%4.884/97/93/70/3F-Score 55/11
WATSCO INCWSO$12.8B$308.46$7.2B$497.0M17.9%0.1710.0%4.125/97/94/71/3F-Score 68/11
APPLIED INDUSTRIAL TECHNOLOGIES INCAIT$10.9B$297.60$4.6B$393.0M21.3%0.3110.9%3.326/95/94/71/3F-Score 57/11
POOL CORPPOOL$7.7B$216.20$5.3B$406.4M34.3%1.0111.0%2.243/96/94/71/3F-Score 56/11